Clearside Biomedical, Inc.

Release Summary

Clearside Biomedical, a clinical biopharmaceutical company developing drugs for the eye, announces last patient enrolled in Phase 2 trial for macular edema associated with retinal vein occlusion.

Clearside Biomedical, Inc.